Company Profile

Natera Inc (AKA: GSN~Gene Security Network)
Profile last edited on: 3/6/2023      CAGE: 48FG5      UEI: C3ZKLH9BHYC1

Business Identifier: Cell-free DNA testing to elevate the science and utility of prenatal testing.
Year Founded
2004
First Award
2006
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13011 McCallen Pass Building A Suite 100
San Carlos, CA 78753
   (650) 249-9090
   info@natera.com
   www.natera.com
Location: Multiple
Congr. District: 14
County: Travis

Public Profile

Previously doing business as Gene Security Network, Natera, Inc. is a genetic testing company designing targeted assays to analyze tiny quantities of DNA: elevating the science and utility of prenatal testing. Fairly SBIR active in the arly years, but now longtime having outgrown SBIR eligibility, the defined mission of the company is to help families diagnose and manage genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, currently offering a host of preconception and prenatal genetic testing services primarily to OBGYN physicians and in-vitro fertilization centers. In 2013, the company launched Panorama, a safe, simple test for pregnant women that screens for the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Tests developed by Natera have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Natera was honored in 2014 to be selected to attend and participate in the famous, highly exclusive Davos World Economic Forum.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : NTRA
IP Holdings
250-500

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Matthew Rabinowitz -- President and Chief Executive Officer

  Steve Chapman -- Vice President of Commercial Operations

  Matthew Hill -- Vice President, Research

  Dave Johnson -- Director of Research and Development

  Jennifer Keller -- Vice President, Clinical Affairs and Medical Education

  Solomon Moshkevich -- Vice President of Marketing and Business Development

  Dan Potter -- Laboratory Director

  Jonathan Sheena -- Chief Technology Officer. Founder

  Asim Siddiqui -- Vice President, Product Development

  Styrmir Sigurjonsson -- Director of Statistics

  Joshua Sweetkind-Singer -- Director of Statistics